$MLYS 4 SEC Filings

Filed On	Filing
20 Oct 2026	Form 4: Coats Lonnel, Director Received 12,400 shares as a grant or award · Granted 16,600 Stock Option
20 Oct 2026	Form 4: Peterson Kristine, Director Received 12,400 shares as a grant or award · Granted 16,600 Stock Option
02 Oct 2026	Form 4: Congleton Jon, Director Sold 75,000 shares ($1.91M)
24 Sep 2026	Form 4: Slingsby Brian Taylor, Director Sold 104,320 shares ($3.01M)
22 Sep 2026	Form 4: Warren Eric, Chief Commercial Officer Received 7,438 shares by exercise or conversion ($98.5K) · Sold 7,438 shares ($209K)
17 Sep 2026	Form 4: Karydas Daphne, Director Received 3,000 shares by exercise or conversion ($36.1K) · Sold 3,000 shares ($85.7K)
25 Aug 2026	Form 4: Warren Eric, Chief Commercial Officer Received 7,437 shares by exercise or conversion ($98.5K) · Sold 7,437 shares ($193K)
12 Aug 2026	Form 4: Ferguson James J. Iii, Chief Medical Officer Received 102,400 shares as a grant or award · Granted 135,000 Stock Option
12 Aug 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 2,170 shares by exercise or conversion ($34.7K) · Sold 2,170 shares ($58.8K)
23 Jul 2026	Form 4: Warren Eric, Chief Commercial Officer Received 7,438 shares by exercise or conversion ($98.5K) · Sold 7,438 shares ($200K)
20 Jul 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 416 shares by exercise or conversion ($6.42K) · Sold 416 shares ($11K)
15 Jul 2026	Form 4: Congleton Jon, Director Sold 10,700 shares ($291K)
15 Jul 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 14,058 shares by exercise or conversion ($102K) · Sold 14,058 shares ($388K) · Sold 6,349 shares ($169K)
10 Jul 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 2,171 shares by exercise or conversion ($34.7K) · Sold 2,171 shares ($65.8K)
30 Jun 2026	Form 4: Congleton Jon, Director Sold 75,000 shares ($1.96M)
30 Jun 2026	Form 4: Warren Eric, Chief Commercial Officer Received 104,124 shares by exercise or conversion ($1.38M) · Sold 104,124 shares ($2.7M)
17 Jun 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 3,542 shares by exercise or conversion ($36.1K) · Sold 9,890 shares ($235K) · Received 4,584 shares by exercise or conversion ($65.8K) · 1 more
17 Jun 2026	Form 4: Karydas Daphne, Director Received 3,000 shares by exercise or conversion ($36.1K) · Sold 3,000 shares ($75K)
12 Jun 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 2,170 shares by exercise or conversion ($34.7K) · Sold 2,170 shares ($54.3K) · Received 6,349 shares by exercise or conversion ($6.86K) · 1 more
19 May 2026	Form 4: Rodman David Malcom, Chief Medical Officer Received 417 shares by exercise or conversion ($6.44K) · Sold 417 shares ($11.5K)

Comments